Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v10-EN Version v4-EN
Language English English
Date Updated 2020-01-18 2019-05-22
Drug Identification Number 00878936 00878936
Brand name NORVASC TAB 10MG NORVASC TAB 10MG
Common or Proper name Norvasc 10mg Norvasc 10mg
Company Name BGP PHARMA ULC BGP PHARMA ULC
Ingredients AMLODIPINE AMLODIPINE
Strength(s) 10MG 10MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 250's 250's
ATC code C08CA C08CA
ATC description SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF. SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF.
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date 2019-05-31
Actual start date 2019-05-24
Estimated end date Unknown Unknown
Actual end date 2020-01-17
Shortage status Resolved Anticipated shortage
Tier 3 Status No No
Company comments Other presentation available: Bottles of 100's. No impact on Norvasc 5mg. Other presentation available: Bottles of 100's. No impact on Norvasc 5mg.
Health Canada comments